ALN-KHK
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALN-KHK, covering 2025-05-07 to 2025-05-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM [Phase 1, Phase 2]